Sumod-ong, Pedro .

HRN: 05-11-16  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/19/2022
CLINDAMYCIN 150MG/ML, 4ML (AMP)
05/19/2022
05/25/2022
IV
600mg
Q8
Cutaneous Abscess
Waiting Final Action 
05/21/2022
CEFTRIAXONE 1G (VIAL)
05/21/2022
05/28/2022
IV
2g
OD
Cutaneous Abscess
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: